Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Genetic and epigenetic factors determining MASLD have been recently reviewed by Jonas and Schurmann (Jonas and Schurmann 2021), and the role of gut microbiota in mediating MASLD development was summarized by Campo et al
PLoS One 8 , e54206 (2013)
But the same 2025 review that catalogs those effects also underscores that only three human clinical trials have been published and that the compound remains investigational, with regulators having flagged it precisely because human safety and efficacy are not established
Animal Model:Neonatal Sprague-Dawley rats (male, 18-22g, postnatal day 7), hypoxic-ischemic brain damage (HIBD) model [2] Dosage:100 mg/kg Administration:Intraperitoneal injection, once daily, for 14 consecutive days starting 24 hours after HIBD induction Result:Brain injury: Reduced infarct volume by 40% compared to the HIBD control group as measured by triphenyltetrazolium chloride (TTC) staining
US$ 24.19
US$ 20.78
US$ 27.39
US$ 26.48
US$ 24.05
US$ 23.04
US$ 26.83
US$ 29.86
US$ 21.23
US$ 21.91
US$ 28.97
